What makes a drug “special”?

A recent paper by Kacerek and Mattingly (2025) aims to answer why certain drugs are defined as “specialty” drugs and others are not. They first cite an Office of the Inspector General (OIG) report: The OIG found that there was no standard definition in Medicaid and that Medicaid programs used more than 100 different characteristics to…

Read More

Adventist HealthCare Teams Up with Culina Health to Expand Access to Nutrition Care

Digital nutrition company Culina Health is joining forces with Adventist HealthCare’s clinically integrated network of more than 2,400 providers. Under the partnership, Adventist physicians will have direct access to Culina Health’s dietitians, who provide patients with virtual, personalized nutrition counseling. The post Adventist HealthCare Teams Up with Culina Health to Expand Access to Nutrition Care…

Read More

Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact With Orano

Sanofi’s equity investment in the new Orano Med entity comes a month after the pharmaceutical giant struck a €100 million deal to license a clinical-stage radiopharmaceutical developed for neuroendocrine tumors. Orano Med develops targeted cancer therapies based on lead-212, an alpha-emitting isotope. The post Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact…

Read More